Investigating how myofibroblasts contribute to lung scarring in pulmonary fibrosis
E-Box Accessibility in Myofibroblasts in Pulmonary Fibrosis
This study is looking at how certain cells in the lungs, called myofibroblasts, behave in people with idiopathic pulmonary fibrosis (IPF) to help find new ways to treat this lung disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11049284 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of myofibroblasts in idiopathic pulmonary fibrosis (IPF), a serious lung condition that leads to scarring and respiratory failure. By using advanced techniques like single nucleus assay for transposase-accessible chromatin sequencing, the researchers aim to uncover how specific genetic elements, particularly E-Box motifs, regulate the behavior of myofibroblasts in the lungs of patients with IPF. This study will provide insights into the molecular mechanisms driving lung fibrosis, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with idiopathic pulmonary fibrosis.
Not a fit: Patients with other forms of lung disease or those without a diagnosis of pulmonary fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that target the mechanisms of lung scarring in pulmonary fibrosis, improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding the role of myofibroblasts in lung diseases, making this approach both relevant and potentially impactful.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Kass, Daniel J — University of Pittsburgh at Pittsburgh
- Study coordinator: Kass, Daniel J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.